38 completed, 9 terminated, 7 unknown, 1 not yet recruiting. 18 Phase 4, 17 Phase 3, 6 Not applicable, 5 Phase 1, 3 Phase 2.
Follow Vifor Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency Iron Carboxymaltose, Dapagliflozin 10mg Tab, Placebo of Iron Carboxymaltose - Heart Failure, Systolic, Iron Deficiencies | Phase 3 | Not yet recruiting | Hospital de Clinicas de Porto Alegre | 99 | 2024-05-24 | 2024-06-03 |
| Patiromer Trial in CKD Stage IIIB to V Veltassa Oral Powder Product, Placebo - Hyperkalemia | Phase 3 | Terminated | Mario Negri Institute for Pharmacological Research | 2 | 2023-08-02 | 2024-11-12 |
| Improving Knowledge in Heart Failure Inpatient With Therapeutic Education Patient therapeutic education - Heart Failure With Reduced Ejection Fraction, Heart Failure; With Decompensation | Not applicable | Terminated | University Hospital, Geneva | 38 | 2022-12-13 | 2024-03-26 |
| Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment Blood sampling - Iron-deficiency | Not applicable | Completed | Vifor Pharma | 888 | 2022-11-15 | 2025-03-28 |
| CKD-aP Among Adults on Dialysis in Switzerland CKD-aP - Chronic Kidney Diseases, Dialysis | Completed | University of Applied Sciences of Western Switzerland | 401 | 2022-09-01 | 2023-11-18 | |
| mHealth for Phosphorus Management in CKD. mHealth App - Dialysis Related Complication | Not applicable | Unknown | Hospital Universitari de Bellvitge | 50 | 2022-06-01 | 2023-09-22 |
| Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists Best Practice Alert - Heart Failure With Reduced Ejection Fraction | Not applicable | Completed | Yale University | 1210 | 2021-11-03 | 2024-08-23 |
| Hyperkalaemia and Its Impact on Therapy with RAASi Hyperkalaemia, Heart Failure with Reduced Ejection Fraction | Completed | Portsmouth Hospitals NHS Trust | 651 | 2021-07-12 | 2024-11-14 | |
| IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors No intervention - Hyperkalemia | Withdrawn | Portsmouth Hospitals NHS Trust | 2021-07-12 | 2025-12-23 | ||
| Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery FEFINJECT - Cerebral Aneurysm Unruptured, Iron Deficiency Anemia | Phase 4 | Unknown | Seoul National University Hospital | 130 | 2020-11-01 | 2020-11-04 |
| Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation Ferritin, iron and iron binding capacity, high sensitive C-reactive protein (CRP) measurement - Iron-deficiency, Atrial Fibrillation | Unknown | Koç University | 1000 | 2019-10-01 | 2022-03-14 | |
| Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Patiromer Oral Powder Product - Hyperkalemia, End Stage Renal Disease | Phase 4 | Completed | Duke University | 36 | 2019-06-20 | 2025-05-30 |
| Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery Ferric carboxymaltose, Placebo - Anemia, Iron Deficiency | Phase 4 | Completed | St Joseph University, Beirut, Lebanon | 194 | 2018-12-15 | 2021-10-11 |
| Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Ferric carboxymaltose, Physiological saline - Coronary Artery Disease, Postoperative Complications | Phase 4 | Unknown | Turku University Hospital | 210 | 2018-10-02 | 2021-04-20 |
| The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland Primary Biliary Cirrhosis | Completed | Fondazione Epatocentro Ticino | 501 | 2015-12-01 | 2025-08-19 | |
| The Use of Iron Therapy for Patients With Anemia After Caesarean Section Ferinject, Ferrous fumarate, Placebo for ferrous fumarate - Postoperative Anaemia | Phase 4 | Terminated | Maastricht University Medical Center | 27 | 2015-03-02 | 2022-08-22 |
| A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) non-pegylated liposomal doxorubicin, Carboplatin, Paclitaxel - Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III | Phase 3 | Completed | GBG Forschungs GmbH | 961 | 2014-12-01 | 2017-07-13 |
| Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia Ferrous fumarate, ferric(III)carboxymaltose - Anemia, Colorectal Carcinoma | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 198 | 2014-11-01 | 2018-08-28 |
| Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency ARM A : IV iron + epoietin zeta, ARM B: IV iron + epoietin zeta sequence, ARM C : single epoietin zeta - Solid Cancer Metastatic Disease, Lymphoid Disease | Phase 4 | Terminated | Centre Francois Baclesse | 24 | 2013-04-01 | 2015-04-29 |
| Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients Surgery | Completed | Johann Wolfgang Goethe University Hospital | 110000 | 2013-01-01 | 2015-09-07 |
Showing 20 of 56. Sign in to see all of them.
Anemia (15) · Anemia, Iron-Deficiency (15) · Iron Deficiencies (15) · Renal Insufficiency, Chronic (5) · Hyperkalemia (4) · Heart Failure (3) · Heart Diseases (2) · Inflammatory Bowel Diseases (2) · Lymphoproliferative Disorders (2) · Aortic Aneurysm, Thoracic (1) · Aortic Valve Stenosis (1) · Atrial Fibrillation (1) · Attention Deficit Disorder with Hyperactivity (1) · Behavior (1) · Carcinoma, Ductal, Breast (1)
ferric carboxymaltose (25) · Iron (7) · Sodium Chloride (5) · Food (3) · Sevelamer (3) · ferrous sulfate (3) · Cyclophosphamide (2) · Ferric Oxide, Saccharated (2) · Saline Solution (2) · ferrous fumarate (2) · Blood Specimen Collection (1) · Broncho-Vaxom (1) · Carboplatin (1) · Digoxin (1) · Doxorubicin (1)
Germany (14) · United States (11) · Switzerland (7) · Austria (6) · Netherlands (6) · Poland (6) · Russia (6) · United Kingdom (6) · France (5) · Romania (5) · Czechia (4) · Spain (4) · Belgium (3) · Croatia (3) · Denmark (3)
Peter J Winkle, MD (3) · Christoph Gasche, Professor (2) · Juergen Floege, MD (2) · Paul R Kalra, Professor (2) · Andreas Schneeweiss, MD, Prof. (1) · Anton Vonk-Noordegraaf, Prof MD PhD (1) · Bernard Favrat (1) · Christian Breymann (1) · Christoph Gasche, MD (1) · Christoph Schindler, MD (1) · Claudio Bassetti, Professor (1) · David Jayne (1) · Dilek Ural, Prof. (1) · Dirk van Veldhuisen, MD (1) · Elvira Bisbe, MD (1)
PMID 40576086, PMID 29656600, PMID 11796024, PMID 17620512, PMID 19212255, PMID 19875408, PMID 19920054, PMID 21982521, PMID 22753087, PMID 23078888, PMID 24251969, PMID 24751822, PMID 24780615, PMID 24891437, PMID 25176939, PMID 25927460, PMID 25928811, PMID 26063068, PMID 26123286, PMID 26401247, PMID 27163948, PMID 27545509, PMID 28095881, PMID 28339831, PMID 28701470, PMID 29134606, PMID 29181702, PMID 29944518, PMID 30528802, PMID 30612116, PMID 32163106, PMID 32588430, PMID 33191846, PMID 34252375, PMID 34801353, PMID 35220460, PMID 36375780, PMID 36863386, PMID 37380568, PMID 37943221, PMID 38287253, PMID 39145520, PMID 41342691
2014 (1), 2023 (1)